These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30232768)

  • 21. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction.
    Chu P; Pandya A; Salomon JA; Goldie SJ; Hunink MG
    J Am Heart Assoc; 2016 Mar; 5(3):e002737. PubMed ID: 27025969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B; Barreto-Filho JA
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501
    [No Abstract]   [Full Text] [Related]  

  • 24. How the Seven Countries Study contributed to the launch and development of cardiovascular epidemiology in Italy. A historical perspective.
    Menotti A; Puddu PE
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):368-383. PubMed ID: 31848054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel personalized approach to cardiovascular prevention: The VIVOPTIM programme.
    Blacher J; Femery V; Thorez F; Sosner P; Dibie A; Pavy B; Beaunier P; Chabot JM; Benzaqui M; Ohannessian R; Garnier M; Dubois A; Isnard-Bagnis C; Durand-Zaleski I
    Arch Cardiovasc Dis; 2020 Oct; 113(10):590-598. PubMed ID: 33011157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical considerations in cardiovascular prevention.
    Follath F
    Fundam Clin Pharmacol; 2009 Dec; 23(6):669-73. PubMed ID: 19500153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
    ; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D;
    Eur Heart J; 2011 Jul; 32(14):1769-818. PubMed ID: 21712404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediterranean Personalized Diet Combined with Physical Activity Therapy for the Prevention of Cardiovascular Diseases in Italian Women.
    Di Renzo L; Cinelli G; Dri M; Gualtieri P; Attinà A; Leggeri C; Cenname G; Esposito E; Pujia A; Chiricolo G; Salimei C; De Lorenzo A
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33187188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention: From the cradle to the grave and beyond.
    Dendale P; Scherrenberg M; Sivakova O; Frederix I
    Eur J Prev Cardiol; 2019 Mar; 26(5):507-511. PubMed ID: 30861698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-area variation  of cardiovascular diseases and select risk factors and their association to household and area poverty in South Africa: Capturing emerging trends in South Africa to better target local level interventions.
    Dwane N; Wabiri N; Manda S
    PLoS One; 2020; 15(4):e0230564. PubMed ID: 32320425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document.
    Volpe M; Volpe R; Gallo G; Presta V; Tocci G; Folco E; Peracino A; Tremoli E; Trimarco B;
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):313-329. PubMed ID: 28523635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifestyle advice and interventions for cardiovascular risk reduction: A systematic review of guidelines.
    Khanji MY; van Waardhuizen CN; Bicalho VVS; Ferket BS; Hunink MGM; Petersen SE
    Int J Cardiol; 2018 Jul; 263():142-151. PubMed ID: 29754910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance measures in million hearts: 2 partners' perspective.
    Drozda JP; Holmes DP
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):587-8. PubMed ID: 22811502
    [No Abstract]   [Full Text] [Related]  

  • 36. Platelet Responses in Cardiovascular Disease: Sex-Related Differences in Nutritional and Pharmacological Interventions.
    Gasperi V; Catani MV; Savini I
    Cardiovasc Ther; 2020; 2020():2342837. PubMed ID: 32547635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare.
    Hyun KK; Redfern J; Patel A; Peiris D; Brieger D; Sullivan D; Harris M; Usherwood T; MacMahon S; Lyford M; Woodward M
    Heart; 2017 Apr; 103(7):492-498. PubMed ID: 28249996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk and hypertension control in Italy. Data from the 2015 World Hypertension Day.
    Torlasco C; Faini A; Makil E; Ferri C; Borghi C; Veglio F; Desideri G; Agabiti Rosei E; Ghiadoni L; Pauletto P; Pontremoli R; Stornello M; Tocci G; Galletti F; Trimarco B; Parati G;
    Int J Cardiol; 2017 Sep; 243():529-532. PubMed ID: 28571620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary prevention of cardiovascular disease in China.
    Lu J; Zhang L; Lu Y; Su M; Li X; Liu J; Zhang H; Nasir K; Masoudi FA; Krumholz HM; Li J; Zheng X
    Heart; 2020 Sep; 106(17):1349-1356. PubMed ID: 31980439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.